tiprankstipranks
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market

Silexion Therapeutics (SLXN) Technical Analysis

Compare
138 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Silexion Therapeutics’s (SLXN) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Silexion Therapeutics is a Sell.
Silexion Therapeutics’s (SLXN) 20-Day exponential moving average is 1.22, while Silexion Therapeutics’s (SLXN) share price is $1.14, making it a Sell.
Silexion Therapeutics’s (SLXN) 50-Day exponential moving average is 1.72, while Silexion Therapeutics’s (SLXN) share price is $1.14, making it a Sell.

Silexion Therapeutics (SLXN) Pivot Points

Mar 24, 2025, 06:21 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.98
1.03
1.07
1.12
1.16
1.21
1.25
Fibonacci
1.03
1.06
1.09
1.12
1.15
1.18
1.21
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Silexion Therapeutics (SLXN) Moving Averages

Mar 24, 2025, 06:21 AM
Period
Simple
Exponential
MA5
1.18Sell
1.17Sell
MA10
1.25Sell
1.20Sell
MA20
1.20Sell
1.22Sell
MA50
1.27Sell
1.72Sell
MA100
1.91Sell
7.21Sell
MA200
29.92Sell
33.81Sell
Silexion Therapeutics’s (SLXN) 10-Day exponential moving average is 1.20, while Silexion Therapeutics’s (SLXN) share price is $1.14, making it a Sell.
Silexion Therapeutics’s (SLXN) 100-Day exponential moving average is 7.21, while Silexion Therapeutics’s (SLXN) share price is $1.14, making it a Sell.
Silexion Therapeutics’s (SLXN) stock price is $1.14 and Silexion Therapeutics’s (SLXN) 50-day simple moving average is 1.27, creating a Sell signal.
Silexion Therapeutics’s (SLXN) stock price is $1.14 and Silexion Therapeutics’s (SLXN) 100-day simple moving average is 1.91, creating a Sell signal.
Silexion Therapeutics’s (SLXN) stock price is $1.14 and Silexion Therapeutics’s (SLXN) 200-day simple moving average is 29.92, creating a Sell signal.

Silexion Therapeutics (SLXN) Technical Indicators

Mar 24, 2025, 06:21 AM
Name
Value
Implied Action
RSI (14)
46.20
Neutral
STOCH (9,6)
9.76
Buy
STOCHRSI (14)
17.50
Buy
MACD (12,26)
-0.04
Sell
ADX (14)
23.36
Neutral
Williams %R
-80.00
Buy
CCI (14)
-37.84
Neutral
ATR (14)
0.20
-
Ultimate Oscillator
40.72
Neutral
ROC
8.57
Buy
Silexion Therapeutics’s (SLXN) Relative Strength Index (RSI) is 46.20, creating a Neutral signal.
Silexion Therapeutics’s (SLXN) Trend Strength Indicator (ADX) is 23.36, creating a Neutral signal.
Silexion Therapeutics’s (SLXN) Commodity Channel Index (CCI) is -37.84, creating a Neutral signal.
Silexion Therapeutics’s (SLXN) Price Rate of Change (ROC) is 8.57, creating a Buy signal.

FAQ

Is SLXN a Buy, Hold, or Sell?
Based on SLXN’s technical indicators, SLXN is a Sell.
    What is SLXN’s RSI (14)?
    SLXN’s RSI (14) is 46.20, which suggests SLXN is a Neutral.
      What is SLXN’s MACD?
      SLXN’s MACD is -0.04, which suggests SLXN is a Sell.
        What is SLXN’s 5-day moving average?
        SLXN’s 5-day moving average is 1.18, which suggests SLXN is a Sell.
          What is SLXN’s 20-day moving average?
          SLXN 20-day moving average is 1.20, which suggests SLXN is a Sell.
            What is SLXN’s 50-day moving average?
            SLXN’s 50-day moving average is 1.27, which suggests SLXN is a Sell.
              What is SLXN’s 200-day moving average?
              SLXN’s 200-day moving average is 29.92, which suggests SLXN is a Sell.
                What is SLXN’s Williams % R (14)?
                SLXN’s Williams % R (14) is -80.00, which suggests SLXN is a Buy.
                  What is SLXN’s CCI (14)?
                  SLXN’s CCI (14) is -37.84, which suggests SLXN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis